Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
30.41M | 21.85M | 8.82M | 10.82M | 9.03M | Gross Profit |
17.83M | 8.07M | 3.35M | 5.19M | 4.02M | EBIT |
64.77K | -4.12M | -6.70M | 139.02K | 258.70K | EBITDA |
-4.46M | -4.16M | -6.55M | 170.40K | 399.69K | Net Income Common Stockholders |
-1.48M | -4.19M | -6.68M | -327.04K | 150.96K |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
6.62M | 1.95M | 7.18M | 3.14M | 3.06M | Total Assets |
13.97M | 19.62M | 12.14M | 9.12M | 10.36M | Total Debt |
3.78M | 4.89M | 4.55M | 6.19M | 8.49M | Net Debt |
1.66M | 3.88M | -2.62M | 3.05M | 5.43M | Total Liabilities |
10.50M | 11.96M | 7.33M | 9.68M | 11.42M | Stockholders Equity |
4.65M | 5.17M | 4.81M | -558.95K | -1.41M |
Cash Flow | Free Cash Flow | |||
-4.78M | -4.86M | -4.87M | 730.15K | 718.58K | Operating Cash Flow |
-4.77M | -4.33M | -4.81M | 766.30K | 745.75K | Investing Cash Flow |
6.35M | -1.78M | -12.20K | -179.03K | -401.15K | Financing Cash Flow |
-318.65K | 136.19K | 8.92M | -257.35K | 2.06M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
62 Neutral | $11.72B | 10.43 | -7.10% | 2.91% | 7.41% | -7.94% | |
48 Neutral | $12.34M | ― | -66.08% | ― | 3125.00% | 98.06% | |
46 Neutral | 3.64 | -111.94% | 7.33% | 59.42% | 58.65% | ||
45 Neutral | $2.36M | ― | -91.75% | ― | -9.89% | 47.46% | |
39 Underperform | $10.21M | ― | -34.07% | ― | -78.87% | 85.62% | |
$2.97M | ― | -296.03% | ― | ― | ― | ||
42 Neutral | $4.30M | ― | -8.88% | ― | -96.03% | 95.03% |
On May 30, 2025, HeartCore Enterprises, Inc. entered into a Consulting and Services Agreement with tmsuk Co. Ltd., a Japanese corporation, to assist in tmsuk’s efforts to go public and list on the Nasdaq Stock Market. This agreement marks HeartCore’s 15th Go IPO consulting service win, reflecting steady interest in their services despite IPO market uncertainties. HeartCore will provide various services including assistance with legal and audit firm selection, document translation, and accounting data conversion. Compensation for these services includes $500,000 in fees and a warrant for 3% of tmsuk’s capital stock, subject to shareholder approval. The agreement highlights HeartCore’s strategic positioning in the market and its ongoing expansion efforts, including plans to host a Go IPO seminar in South Korea in September 2025.
On May 24, 2025, HeartCore Enterprises, Inc. received a notice from Nasdaq indicating non-compliance with the $2,500,000 minimum stockholders’ equity requirement for continued listing on the Nasdaq Capital Market. The company has until July 8, 2025, to submit a compliance plan, with potential extensions until November 20, 2025. The noncompliance notice does not immediately affect the trading of the company’s stock, but there is no assurance of regaining compliance.
On May 6, 2025, HeartCore Enterprises, Inc. received a notice from the Nasdaq Listing Qualifications Department indicating noncompliance with the $1.00 minimum bid price requirement for continued listing on the Nasdaq Capital Market. This notification does not immediately affect the trading of the company’s stock, and HeartCore is considering its options to address the issue. The company has until November 3, 2025, to regain compliance, with a potential extension if certain conditions are met. However, there is no assurance that compliance will be regained.